Corporate Partner

Reata Pharmaceuticals Announces FDA Approval of SKYCLARYS™ (Omaveloxolone) for Friedreich’s Ataxia. Learn What this Means for the Mito Community.

Mar 1, 2023

Cyclerion Therapeutics to Discuss CY6463 MELAS Clinical Data at a Webinar Hosted by United Mitochondrial Disease Foundation Company to...

Jun 22, 2022

Cyclerion Therapeutics to Discuss CY6463 MELAS Clinical Data at a Webinar Hosted by United Mitochondrial Disease Foundation Company to...

Jan 9, 2020

Dec 11, 2019

UMDF is proud to shine this month’s Corporate Partner Spotlight on Summit Health Pharmacy. We are grateful to Vince Canazanese, Robin...

Nov 5, 2019

This holiday season, we count on the generosity of corporate partners to make a difference in the lives of those affected by mitochondrial...

Sep 30, 2019

UMDF’s Mitochondrial Medical Symposium has become the place where news breaks on the latest potential treatments and clinical trials. In 2019,...